Alteration of skin immune environment by sand fly saliva across progressive Leishmaniasis
白蛉唾液改变进行性利什曼病的皮肤免疫环境
基本信息
- 批准号:10666688
- 负责人:
- 金额:$ 61.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-15 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:Animal ModelAntigensArthropodsB-LymphocytesBiological ModelsBiopsyBiteCD8-Positive T-LymphocytesCanis familiarisCellsCessation of lifeClinicalComplexDataDermalDermisDiseaseEnvironmentEpidemiologyErythrocytesEventExposure toFemaleHourHumanImmuneImmune responseImmunityImmunotherapyInfectionInfection ControlInflammationInflammatoryIntegration Host FactorsInterventionIntervention StudiesLaboratoriesLeadLeishmaniaLeishmania donovaniLeishmania infantumLeishmaniasisLigandsLutzomyia genusMacrophageMediatingNorth AmericaOrganOutcomeParasitemiaParasitesPhlebotominaePhlebotomusProductivityPropertyPublic HealthRuptureSalivaSalivarySalivary ProteinsSand FliesSiteSkinSouth AmericaTimeTraumaVisceral LeishmaniasisWorkZoonosescohortexhaustexperimental studyfeedingheme oxygenase-1immunoregulationinnovationpreventprogrammed cell death ligand 1programmed cell death protein 1responsetranscriptometransmission processvector
项目摘要
Summary
Visceral leishmaniasis (VL), caused by Leishmania donovani complex spp. causes between 20,000-
40,000 deaths a year. L. infantum is the cause of VL in the Mediterranean basin and imported to both South
and North America. L. infantum is zoonotic with canid reservoirs. Leishmania spp. are transmitted primarily
between mammalian hosts by female Lutzomyia or Phlebotomus sand flies. It has been established that both
sand fly and host factors modulate local dermal immunity when and where parasites first encounter skin,
guiding immunity locally and systemically and impacting infection outcomes. Relatively little is known about the
skin immune environment during progressive VL, how dermal immune changes alter host infectiousness or
responses to immunomodulatory sand fly salivary components. Skin parasite burden in dogs with L. infantum
infection correlates with transmission efficiency, more so than parasitemia, though dogs with late-stage
disease were less infectious than those with mild-moderate disease. We have shown that asymptomatic VL
clinical status was associated in dogs, as in humans, with productive Th1 type responses, while symptomatic
infection correlated with presence of exhausted CD4+ and CD8+ T cells, significant expression of Programmed
Death 1 (PD-1) and its ligand, PD-L1 on both B cells and macrophages and loss of macrophage parasite
clearance. These findings collectively lead us to hypothesize that immune cell responses in subclinical or
clinically infected hosts’ skin, whether from dogs or humans, dictate host infectiousness. We will address this
hypothesis through three specific aims in this proposed work, 1) Identify unique dermal immune environments
in subclinical vs. clinical hosts that alter infectiousness to naïve sand flies, 2) Evaluate how the functions of
sand fly salivary proteins are impacted by skin changes during progressive VL leading to new understanding of
vector saliva-host interactions and how they contribute to infectiousness to sand flies and 3) Evaluate how
alteration of the dermal immune environment through dermal immunotherapy alters bite-site inflammation and
transmission. The work proposed here is therefore significant, as it provides infection control relevant
evidence regarding the dermal microenvironment and how it alters infectivity during progressive L infantum
infection. The studies proposed here are significantly innovative as they quantitatively on a spatial level
assess how parasite burden and different dermal inflammatory states alter infectiousness to sand flies. Using
purified salivary antigens, skin biopsy, histopathologic and transcriptome analysis and a key unique natural
infection cohort, we will determine how progressive VL alters the landscape in which vector salivary proteins
operate with consequences for understanding both host infectiousness and the epidemiology of VL. When
completed, findings from these proposed studies will both underscore how progressive dermal inflammation
impacts reservoir host infectiousness and provide critical data to further assess appropriate interventions to
prevent canine-sand fly-human transmission.
总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christine A Petersen其他文献
Christine A Petersen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christine A Petersen', 18)}}的其他基金
Alteration of skin immune environment by sand fly saliva across progressive Leishmaniasis
白蛉唾液改变进行性利什曼病的皮肤免疫环境
- 批准号:
10527019 - 财政年份:2022
- 资助金额:
$ 61.98万 - 项目类别:
Role of pathogen-derived capping carbohydrates in altering immunity
病原体来源的封端碳水化合物在改变免疫力中的作用
- 批准号:
8081281 - 财政年份:2010
- 资助金额:
$ 61.98万 - 项目类别:
BIOMEDICAL RESEARCH AND TRAINING AT COLLEGE OF THE ATLANTIC
大西洋学院的生物医学研究和培训
- 批准号:
7960070 - 财政年份:2009
- 资助金额:
$ 61.98万 - 项目类别:
Role of pathogen-derived capping carbohydrates in altering immunity
病原体来源的封端碳水化合物在改变免疫力中的作用
- 批准号:
7638500 - 财政年份:2008
- 资助金额:
$ 61.98万 - 项目类别:
Role of pathogen-derived capping carbohydrates in altering immunity
病原体来源的封端碳水化合物在改变免疫力中的作用
- 批准号:
7468584 - 财政年份:2008
- 资助金额:
$ 61.98万 - 项目类别:
BIOMEDICAL RESEARCH AND TRAINING AT COLLEGE OF THE ATLANTIC
大西洋学院的生物医学研究和培训
- 批准号:
7720072 - 财政年份:2008
- 资助金额:
$ 61.98万 - 项目类别:
BIOMEDICAL RESEARCH AND TRAINING AT COLLEGE OF THE ATLANTIC
大西洋学院的生物医学研究和培训
- 批准号:
7610076 - 财政年份:2007
- 资助金额:
$ 61.98万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 61.98万 - 项目类别:
Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 61.98万 - 项目类别:
Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 61.98万 - 项目类别:
Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 61.98万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 61.98万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 61.98万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 61.98万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 61.98万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 61.98万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 61.98万 - 项目类别: